These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26978505)

  • 41. Methylglyoxal increases dopamine level and leads to oxidative stress in SH-SY5Y cells.
    Xie B; Lin F; Peng L; Ullah K; Wu H; Qing H; Deng Y
    Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):950-6. PubMed ID: 25274329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system.
    Barroso-Chinea P; Cruz-Muros I; Afonso-Oramas D; Castro-Hernández J; Salas-Hernández J; Chtarto A; Luis-Ravelo D; Humbert-Claude M; Tenenbaum L; González-Hernández T
    Neurobiol Dis; 2016 Apr; 88():44-54. PubMed ID: 26777664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration.
    Ziebell M; Khalid U; Klein AB; Aznar S; Thomsen G; Jensen P; Knudsen GM
    Neurobiol Aging; 2012 Feb; 33(2):428.e1-5. PubMed ID: 21176997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transgenic Zebrafish Expressing mCherry in the Mitochondria of Dopaminergic Neurons.
    Noble S; Godoy R; Affaticati P; Ekker M
    Zebrafish; 2015 Oct; 12(5):349-56. PubMed ID: 26355474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration.
    Storch A; Ludolph AC; Schwarz J
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1267-86. PubMed ID: 15480838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacochaperoning in a
    Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S
    J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
    Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of estrogen receptors in the resveratrol-mediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female mice.
    Di Liberto V; Mäkelä J; Korhonen L; Olivieri M; Tselykh T; Mälkiä A; Do Thi H; Belluardo N; Lindholm D; Mudò G
    Neuropharmacology; 2012 Feb; 62(2):1011-8. PubMed ID: 22041555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells.
    Wang J; Michelhaugh SK; Bannon MJ
    Eur J Neurosci; 2007 Apr; 25(7):1982-6. PubMed ID: 17439486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression of neuronal dopamine and serotonin transporters DAT and SERT in megakaryocytes and platelets generated from human MEG-01 megakaryoblasts.
    Hohmann S; Schweinfurth N; Lau T; Deuschle M; Lederbogen F; Banaschewski T; Schloss P
    Cell Tissue Res; 2011 Nov; 346(2):151-61. PubMed ID: 22006250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Embryonic stem cells with GFP knocked into the dopamine transporter yield purified dopamine neurons in vitro and from knock-in mice.
    Zhou W; Lee YM; Guy VC; Freed CR
    Stem Cells; 2009 Dec; 27(12):2952-61. PubMed ID: 19750538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The dopamine transporter is differentially regulated after dopaminergic lesion.
    Afonso-Oramas D; Cruz-Muros I; Barroso-Chinea P; Álvarez de la Rosa D; Castro-Hernández J; Salas-Hernández J; Giráldez T; González-Hernández T
    Neurobiol Dis; 2010 Dec; 40(3):518-30. PubMed ID: 20688165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.
    Mackie P; Lebowitz J; Saadatpour L; Nickoloff E; Gaskill P; Khoshbouei H
    Brain Behav Immun; 2018 May; 70():21-35. PubMed ID: 29551693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity.
    Redman PT; Jefferson BS; Ziegler CB; Mortensen OV; Torres GE; Levitan ES; Aizenman E
    Neuroscience; 2006 Nov; 143(1):1-6. PubMed ID: 17027171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
    J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice.
    Vuillermot S; Feldon J; Meyer U
    Exp Neurol; 2011 Nov; 232(1):22-32. PubMed ID: 21820432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations in the Parkinson's Disease-Associated PARK2 Gene Are Accompanied by Imbalance in Programmed Cell Death Systems.
    Konovalova EV; Lopacheva OM; Grivennikov IA; Lebedeva OS; Dashinimaev EB; Khaspekov LG; Fedotova EY; Illarioshkin SN
    Acta Naturae; 2015; 7(4):146-9. PubMed ID: 26798503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.
    Goldberg MS; Pisani A; Haburcak M; Vortherms TA; Kitada T; Costa C; Tong Y; Martella G; Tscherter A; Martins A; Bernardi G; Roth BL; Pothos EN; Calabresi P; Shen J
    Neuron; 2005 Feb; 45(4):489-96. PubMed ID: 15721235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.
    Singh S; Singh K; Gupta SP; Patel DK; Singh VK; Singh RK; Singh MP
    Brain Res; 2009 Aug; 1283():115-26. PubMed ID: 19520064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.